JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 14, 2004; DOI: 10.1124/jpet.103.062653


0022-3565/04/3092-825-832$20.00
JPET 309:825-832, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.062653v2
309/2/825    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhattacharya, A.
Right arrow Articles by Cohen, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhattacharya, A.
Right arrow Articles by Cohen, M. L.

CARDIOVASCULAR

5-Hydroxytryptamine1B Receptor-Mediated Contraction of Rabbit Saphenous Vein and Basilar Artery: Role of Vascular Endothelium

Anindya Bhattacharya, Kathryn W. Schenck, Yao-Chang Xu, Laura Nisenbaum, Elizabeth Galbreath, and Marlene L. Cohen

Lilly Research Laboratories, Eli Lilly & Co., Indianapolis, Indiana

This study characterizes the sumatriptan-sensitive [5-hydroxytryptamine (5-HT)1B/1D] receptor in rabbit saphenous vein and basilar artery. (S)-(-)-1-{2-[4-(4-Methoxy-phenyl)-piperazin-1-yl]-ethyl}-isochroman-6-carboxylic acid methylamide (PNU-109291), a 5-HT1D subtype-selective agonist (human Ki = 2.5 ± 0.07 nM), did not contract either tissue, whereas o-methoxyphenylpiperazide derivative 4F (MPPA-4F), a 5-HT1B subtype-selective antagonist (human Ki = 4.6 ± 0.6 nM) potently inhibited sumatriptan-induced contraction in the saphenous vein and basilar artery. These results suggested that sumatriptan-induced contraction was mediated via the 5-HT1B receptor in these blood vessels. 5-HT1B receptor-mediated contraction was then compared in endothelium-intact and denuded vessels to evaluate the role of the endothelium in regulating sumatriptan-induced contractility in these tissues. The presence of an intact endothelium inhibited 5-HT1B-induced contraction in both tissues. Endothelial denudation or nitric-oxide synthase inhibition with N{omega} nitro-L-arginine methyl ester (L-NAME) (100 µM) increased the efficacy and potency of sumatriptan in the saphenous vein and basilar artery. Surprisingly, in endothelial-denuded vascular tissues, L-NAME (100 µM) also significantly increased the maximal 5-HT1B receptor-induced contraction in both tissues, with no effect on potency of sumatriptan. The effect of L-NAME after endothelial denudation may reflect the presence of a low density of residual endothelial cells as estimated by CD31 antibody staining combined with the modulating effect of nitric oxide released from nonendothelial cells in vascular tissue. Endothelial modulation was specific to 5-HT1B receptors because removal of the endothelium did not significantly alter contraction to norepinephrine, histamine, prostaglandin, or potassium chloride in the saphenous vein or basilar artery.


Received December 1, 2003; accepted December 31, 2003.

Address correspondence to: Dr. Anindya Bhattacharya, Roche Pharmaceuticals, 3431 Hillview Ave., Palo Alto, CA 94304. E-mail: anindya.bhattacharya{at}roche.com




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. E. Linder, W. Ni, J. L. Diaz, T. Szasz, R. Burnett, and S. W. Watts
Serotonin (5-HT) in Veins: Not All in Vain
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 415 - 421.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
D. M. Angeles and W. J. Pearce
Effect of dopamine on vascular reactivity in near-term lamb carotids: role of the endothelium.
Biol Res Nurs, October 1, 2006; 8(2): 97 - 103.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.